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INTRODUCTION
The World Health Organization (WHO) estimates that the majority of the population of most non-industrial countries still relies on traditional forms of medicine for everyday health care. In many countries up to 80-90 % of the population are in this category.
Traditional medicine has been defined as "the sum total of the knowledge, skills and practices based on the theories, beliefs and experiences indigenous to different cultures, whether explicable or not, used in the maintenance of health, as well as in the prevention, diagnosis, improvement or treatment of physical and mental illnesses" (1) .
Another definition relevant for traditional communities is the "traditional ecological knowledge (TEK)". As a holistic concept, as the science of ecology TEK includes the set of traditional knowledge, innovations and practices and plays an important role in traditional medicine and health systems (2) . Different than the western knowledge transmission systems TEK in traditional communities are done by "collective memory" (3) .
Human kind faced an explosion of accumulation of information about the universe he lives in. The revolution in science had started with the Renaissance and increasingly developed itself and Ankara Ecz. Fak. Derg., 36 (2) When innovations are considered, basically, results of western science is recalled. However, set of inventions that were the fruitful results for thousands of years of knowledge accumulation based on experiences of the traditional societies are also real inventions and are subject to IPR.
Cure of a disease which is unknown for modern medicine is a field which has one of the most interest and research has been made on and new problems arise about the IPR of the local people.
Conceptual framework on the domains and relations of property and related rights presents a variety of perception to the issue (4-6). Biopiracy or simply using information without giving any benefit for the owner of the entity or information is a threat for future but also a fact at the moment and has many legal consequences (7) .
IPR have become a metaphor to describe indigenous ownership of total traditional knowledge also, generating options for contractual mechanisms to ensure benefits return to source cultures and countries. The IPR debates illuminates the vitality of biodiversity for human health.
From ancient to modern times, plants have been the cornerstone of pharmacy. But, as time passes, the extinction rate of species and cultures continues to accelerate and human health further deteriorates from diseases for which no cure yet exist. Thus, the value of plants for medicines is more widely recognized and the IPR connected with their use have been debated worldwide (8) . The plant chemicals that have evolved to increase plants resistance may also provide protection and be therapeutically useful for human health (8, 9) . In the past, companies from the more developed north have taken the knowledge of the indigenous peoples of the less developed, but biologically diverse tropical countries and converted medicinal herbs into pharmaceutical products without providing any payment to the providers of the knowledge.
Traditional Medicinal Plants and Its Market
The global market for plant based drugs has been estimated at $43 billion. There is an increasing trend for the use of herbal medicines globally (10) . Traditional medicine has a dual meaning in Third World and civilized modern -mainly western-countries. Traditional medicine in the developing countries and especially in the third world is not an alternative but is an essential component of their health systems because of its cost and easy access. "When dealing with traditional medicine, one is dealing with issues related to biodiversity conservation, protection, preservation and promotion of cultural heritage and technology transfer" (11) . Traditional medicines represent an alternative, an option, for people in modern countries. As well as forming the basis of modern medicine, in Europe, North America and Asia there is a growing need (8-15%
annually) for the popular and efficient herbal species (12) . But main reason in choice lies in the cultural differences such as, in an enquiry only 3 percent of people form USA claimed that they used traditional medicine in the previous years (13) . However, in Germany which has a strong traditional herbal medicine use, this figure was 31 percent and they used phyto-pharmaceutical (herbal medicine) preparations sold as over-the counter (14) .
Agreement on Trade Related Intellectual Property Systems (TRIPS)
Since its inception, the Agreement on Trade Related Intellectual Property Systems (TRIPS), which imposes uniform standards for intellectual property protection, has raised considerable controversy, due to fears that its implementation may entail price increases for pharmaceuticals, which would reduce peoples's access to the medicines they need, notably in developing countries.
So far, much of the discussion has focussed on modern medicines. From a developing country's perspective, when looking into the issue of IPR for modern medicines, the objectives are clear, and the strategies that can be used to achieve those objectives are known, though their implementation may be difficult. The same cannot be said with regard to traditional medicine. TRIPS makes no reference to the protection of traditional knowledge; does not acknowledge or distinguish between indigenous, community-based knowledge and that of industry. Traditional medicine is intertwined with access to biological and genetic resources, and with the knowledge of local and indigenous communities regarding their therapeutic properties. Thus, at the national level, a careful assesment of the objectives and possible implications of IPR protection of traditional medicine should be made (15) .
Traditional Medicine and Intellectual Property Rights
Contribution -Without keeping traditional systems alive, IPR will not work for traditional medicine and it cannot be thought without conserving biodiversity.
-Although CBD aims to protect rich biodiversity may aid in protection of access and sharing of the rich and powerful to the sources.
-Until now people suffering from poverty, which are inhabiting biodiversity rich areas couldn't be successfully incorporated into legal mechanisms of IPR which can be a successful tool for keeping inventive and novel indigenous knowledge while making a difference in economically poor communities, nations and individuals (4).
Role of Ethnobotany and ethnobotanist
Although science of ethnobotany is a tool to share traditional and indigenous knowledge 
Actions Could and Should Be Taken
-Countries should ratify and nationally implement the CBD if they have not already done so.
-National and international enforcement mechanisms in the IPR that ensure legal access to genetic resources and traditional knowledge should be fully developed and used.
-The TRIPS Agreement and national legislation should be clarified to avoid granting patents over naturally occuring genetic resources and biological discoveries. Ankara Ecz. Fak. Derg., 36 (2) 135 -151, 2007 143 -Political and legal flexibility in the existing international arrengements and negotiations to design and implement defensive and positive national sui generis (specially generated) systems to protect traditional medicinal knowledge should be maintained and enhanced.
-Broad and effective participation of indigenous and other local communities in all United Nations (UN) discussions and negotiations on genetic resources and traditional knowledge should be supported and ensured, and permanent mechanisms for participation created (22) .
Successful Case Stories
-There are very good Indian experiences related with the subject and they can be used as a model for other countries. The emergence of "Honey Bee Network" in 1988-89 signified a point of departure in thinking about the way that should deal with people's creativity, knowledge systems and conservation ethics. The growth of the Honey Bee Network required an institutional support and it was felt that an independent support structure was much needed which could help to sustain Honey Bee newsletter and it's associated activities. SRISTI (Society for Research and Initiatives for Sustainable Technology and Institutions) and its research programmes were the results of that realization (23).
-In Cameroon, the need to ensure adequate protection of medicinal plants in an agreement with the US National Cancer Institute (NCI) led to the inclusion of access and benefit-sharing provisions for genetic reseources in the new 1994 Forestry Law (24,25).
-In Peru, the know-how licensing regime adopted by the International Cooperative Biodiversity Groups (ICBG) project strongly influenced the preparation of a draft law for the protection of indigenous collective property rights (26) . While marking a significant step towards the generation of sui generis legislation to protect traditional knowledge rights, the Peruvian process has highlighted conflicts of perspective, legal vision and interests that must be overcome in order to prepare measures that respond to indigenous and local community priorities rather than serving the interests of the commercial sector and national elites (27) .
-The root of the turmeric plant (Curcuma longa) has long been used in Asian societies in cooking, cosmetics, and medicine. In traditional Indian Ayurvedic Medicine it is used to treat anemia, asthma, burns, conjunctivitis, dental problems, diabetes, diarrhea, pain, and many other ailments. In recent years, turmeric has attracted the attention of mainstream medical community as well. In 1995, two Indian scientists at an American university received a U.S. patent for a method of using turmeric to treat wounds. In response to a challenge filed by an Indian research What do these cases tell us about channelling benefits from commercialization of traditional knowledge back to the originating communities? One might categorize solutions as follows:
1.Harmonize IPR laws. The "TRIPS Solution" is to harmonize legal protections across countries, which implies introducing rich country IPR regimes into poor countries. From this point of view, uneven IPR protection generates uneven commercialization.
2.Reform rich country
IPRs. An alternative view is that IPR regimes in rich countries are the problem, and therefore all governments should eliminate patentability of plants ("no patents on life") and require disclosure of traditional knowledge used.
3.Place ethnobotanical knowledge in the public domain. Much traditional knowledge is oral tradition, it must be documented and published. This strives to ensure that nobody will commercialize traditional knowledge.
4.
Create knowledge-sharing contracts. Introduction of contracting mechanisms and creation of tollgates on the transfer of knowledge are obligatory.
5.Promote indigenous commercialization.
Commercialization at home must be realized, irrespective of industrial country property rights. Generally it is known that; traditional medicines are made for traditional uses, not for future sale in distant locations. The challenge facing developing countries is to unpackage knowledge from traditional products and repackage it for commercial markets. The existence of IPRs is unsufficient to meet this challenge (28) . Another disadvantage is the difference in the community structure in every country. Benefit sharing mechanisms of IPR should also be. There cannot be a magic solution for every situation.
CONCLUSION
Deciding whether patenting or legalizing the plants will help the less favorable indigenous people.
Sui generis systems are good alternatives for the improvement of TRIPS and sometimes mentioned as TRIPS plus. Third world needs a modified form of TRIPS (35, 36) . However there is sceptisism that this sui generis option will be adequate to provide any significant alternatives to existing IPRS (37) . Change in way of thinking is very important and economical entities should base on cooperation rather than competition. Pharmaceutical companies should be positive towards traditional people during their quest for new phyto-pharmaceuticals and case of Shaman Pharmaceuticals should be discussed as a primary model for such companies (38, 39) .
Linking IPR with Convention of Biodiversity is very important. Extinction will annihilate plants and traditions and indigenous life will also take its toll. Tsunami of globalization destroys everything or changes to money. Adaptation lived by local people to capitalist systems are against the spirit of traditional medicine and CBD. The basic dilemma is if one thing has no value in money it may dissappear, if it has value it will be used by the most powerful player which has the biggest capital and infrastructure. In both cases traditional people may suffer.
Ethnobotanist should not be just collectors of information basically for their scientific purposes or should not become simply as the traders of knowledge. Publications, meetings and decisions pass the responsibility from scientists to application bodies but not the ultimate solution without action. Ethnobotanists cannot escape from responsibility after a publication or anything else else. They should be keeper of both the information gathered and the rights of the people which the knowledge originated. Ethnobotanical information should accumulate both in scientific media and digital libraries specially formed for this subject. Combining the Traditional Knowledge Digital Library with the International Patent System through an International Traditional Knowledge Resource Classification System will be a very important improvement towards future of the situation.
Last but not the least, adaptation of the healer which is doing this action for a mission and not for money into the commerce is difficult. Although as a tool for exchange in the beginning, money has its own value today and makes us not to see other values in life.
